1. Medtech Insight

ACC 2018 Preview: Zoll's LifeVest, Abbott's HeartMate 3 And Amplatzer, Late-Breaking Trial Devices

 
• By Reed Miller

New clinical data with the potential to change clinical practice will be presented at the 2018 American College of Cardiology Scientific Session and Expo in Orlando, Fla., Mar. 10-12. Among the planned late-breaking trials and featured research presentations is a study of Zoll's LifeVest wearable external cardioverter-defibrillator following a heart attack; new results from a trial of Abbott's Amplatzer PFO-closure device, and long-term data on Abbott's HeartMate 3 ventricular assist device.

The 2018 American College of Cardiology Scientific Session and Expo in Orlando, Fla., March 10-12, will include 37 presentations of clinical trial data, either in Late-Breaking Trials or Featured Clinical Research sessions. Among these, 14 are related to in vitro diagnostics, advanced imaging or device interventions. Here are some of the trial presentations scheduled for the ACC meeting that are expected to impact medtech:

Mandeep Mehra of Brigham & Women's Hospital in Boston will present the long-term results from

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Cardiology

More from Device Area